
News
2020
- Nov 27Technology CrisBio Science
Chrysalises as natural production units for recombinant subunit vaccines
- Sep 24Company CrisBio Technology
Algenex inaugura su nueva planta de fabricación de vacunas en Tres Cantos con capacidad de producción de hasta 100 millones de dosis vacunales
- Sep 13CrisBio Company
Algenex raises €7.4 million in financing round
- Sep 08CrisBio Company
Algenex cierra nueva ronda de financiación por 7,4 millones para afrontar sus nuevos proyectos en salud humana
- Aug 07Company CrisBio
Algenex obtiene 470.000 euros del CDTI para desarrollar productos para el control y la prevención del COVID-19
- Jul 21Company CrisBio
Algenex and Global DX announce positive evaluation of Herdscreen® ASFV antibody test for African Swine Fever
- Jul 15Company
Junta general de accionistas
- Jul 08Company Science
Día Mundial de la Zoonosis: Más del 60% de las enfermedades infecciosas humanas provienen de animales
- Jul 08Company
Algenex impulsa la creación de una plataforma tecnológica de producción industrial de vacunas en España
- May 13Science Technology
Algenex obtiene financiación del CDTI para desarrollar productos contra la COVID-19
- May 05Company CrisBio
Algenex advances insect-based vaccine production technology in human health
- May 05Company CrisBio
Algenex ha desarrollado una tecnología basada en insectos que aceleraría la producción de nuevas vacunas
- Mar 02Company CrisBio
Algenex to open new manufacturing facility and hunt for series C this year
- Feb 10Science Technology
Algenex presents at LSX London
2019
- Dec 06Science Technology
Bioinnovo, Algenex reinforce vaccine molecule arrangement
- Dec 02Company Science Technology
Algenex and FATRO sign commercial license agreement for development of a second CrisBio®-based vaccine
- Dec 02Company CrisBio Science Technology
Algenex adds to Fatro relationship with second vaccine license
- Oct 26Science Technology
First dossier with CrisBio filed to EMA
- Oct 15Company Science Technology
First Algenex CrisBio®-based vaccine submitted to European Medicines Agency
- Oct 11Company
Convocatoria de Junta General Extraordinaria de socios
- Jul 26Company
Junta General Extraordinaria de socios
- May 28Company Science Technology
Algenex and Global DX sign agreement to develop and commercialize diagnostic products for the detection of African Swine Fever
- May 25Science Technology
ALGENEX supports development of recombinant biologics with €4m funding round
- Mar 22Science Technology
ALGENEX selected to present at the Animal Health Investment Innovation Showcase
- Mar 13Science Technology
ALGENEX appoints new Strategic Advisory Board (SAB)
- Mar 05Company Science Technology
ALGENEX closes funding round and strengthens team with key senior manager appointments
2018
- Oct 15Company
Algenex galardonada por la Asociación Española de Científicos
2017
2015
- Sep 08Company CrisBio Science Technology
ALGENEX has signed its first commercial license agreement with FATRO